Given the lower growth forecast, analysts express concern that should the P/E fall in line with the growth outlook, share price might decline. Investors currently holding onto their stock could face future disappointment.
Issuing new shares has diluted EPS growth, potentially affecting the stocks appeal to investors. Despite improved profits, slower EPS growth due to dilution is worrying. Future company profitability estimates are key.
The market tempers expectations for IDACORP growth despite consistent EPS growth. Warning signs surface in IDACORP's investment analysis. Though its strategy attracted investors thanks to better 5yr returns.
Upgrades •$アゴラ(API.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50 •$アルジェンX(ARGX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278) •$アイダコープ(IDA.US)$: Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108) •$ジャックス パシフィック(JAKK.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $21 •$コカ・コーラ・フェムサ(KOF.US)$: Barclays Upgrades to Overweight from Equal Wei...
アイダコープに関するコメント
• $アゴラ(API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $アルジェンX(ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $アイダコープ(IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $ジャックス パシフィック(JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $コカ・コーラ・フェムサ(KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
まだコメントはありません